Pregabalin and Gabapentin Prospective Clinical Trial for the Treatment of Sciatica: A Randomised, Double-Blind, Cross-over Study
Phase of Trial: Phase III
Latest Information Update: 03 Apr 2019
Price : $35 *
At a glance
- Drugs Gabapentin (Primary) ; Pregabalin (Primary)
- Indications Sciatica
- Focus Therapeutic Use
- Acronyms PAGPROS
- 15 Oct 2018 Results published in the JAMA Neurology
- 15 Oct 2018 Status changed from not yet recruiting to completed.
- 20 Dec 2017 Planned number of patients changed from 36 to 38.